ICS use maintains RNFL rate

Article

Intranasal corticosteroids (ICS) maintain retinal nerve fibre layer (RNFL) thickness and optic nerve cup to disc ratio among patients with glaucoma or glaucoma suspect.

Intranasal corticosteroids (ICS) maintains retinal nerve fibre layer (RNFL) thickness and optic nerve cup to disc ratio among patients with glaucoma or glaucoma suspect.

Dr Johnson and his team, Neuro-Ophthalmology Unit, Mason Eye Institute, included 170 glaucoma or glaucoma suspect patients in a retrospective study. The rates of change in RNFL thickness and fast optic disc scan data were compared between ICS users and non-ICS users.

The results revealed there were no significant differences in superior, nasal, inferior and temporal RNFL thickness between ICL users and non-users. There was also no significant difference between the groups in horizontal and vertical cup to disc ratio.

Short-term ICS use presented no significant differences in both optic to cup disc ratio and RNFL thickness in glaucoma or glaucoma suspects.

The abstract was recently published in the European Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.